Ubiquitin-specific protease 14 promotes prostate cancer progression through deubiquitinating the transcriptional factor ATF2
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 524 (1) , 16-21
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The role of UBL domains in ubiquitin-specific proteasesBiochemical Society Transactions, 2012
- ATF2 – at the crossroad of nuclear and cytosolic functionsJournal of Cell Science, 2012
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14Nature, 2010
- Stability and DNA-Binding Ability of the bZIP Dimers Formed by the ATF-2 and c-Jun Transcription FactorsJournal of Molecular Biology, 2010
- Emerging roles of ATF2 and the dynamic AP1 network in cancerNature Reviews Cancer, 2010
- The role of ATF‐2 in oncogenesisBioEssays, 2008
- The p38 transduction pathway in prostatic neoplasiaThe Journal of Pathology, 2005
- Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesisOncogene, 2001
- Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and ThreonineJournal of Biological Chemistry, 1995
- A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequenceNature, 1989